[VRTX] QoQ Quarter Result on 31-Mar-2013 [#Q1]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
08-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- -304.50%
YoY- -436.30%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 351,157 221,700 310,750 328,368 333,994 336,006 418,305 -10.98%
PBT -340,253 -129,406 -63,511 -442,940 -80,772 -5,112 -14,405 718.51%
Tax -155,704 -751 -1,799 -130,313 -2,696 21,355 20,063 -
NP 44,285 -124,125 -57,165 -308,016 -76,148 -57,543 -64,931 -
Tax Rate - - - - - - - -
Total Cost 306,872 345,825 367,915 636,384 410,142 393,549 483,236 -26.05%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin 12.61 -55.99 -18.40 -93.80 -22.80 -17.13 -15.52 -
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
EPS 0.19 -0.54 -0.26 -1.43 -0.35 -0.27 -0.31 -
EPS Diluted 0.19 -0.54 -0.26 -1.43 -0.35 -0.27 -0.31 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.